Evidence map›Paper›PMID 18678605›Full record

ArticleJournal of leukocyte biology2008

Chronic calorie restriction attenuates experimental autoimmune encephalomyelitis.

Laura Piccio, Jennifer L Stark, Anne H Cross

3 registry-linked trialsAbstract read
In one paragraph

Article in Journal of leukocyte biology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 120 papers.

0numbers the graph read from it
0cells of the map it votes in
120citing papers in PubMed
4.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01538355 nacompletednot on this mapstarted 2012, after this paper: background citation

A Randomised Controlled Pilot Study to Compare the Effects of Prolonged Fasting and Ketogenic Low Glycemic Load Treatment on Health Related Quality of Life in Relapsing-remitting Multiple Sclerosis.

TypeinterventionalSponsorCharite University, Berlin, GermanyRan2012 to 2020Enrolled48ConditionsRelapsing-Remitting Multiple SclerosisArmsProlonged Fasting, Ketogenic low glycemic load treatment, Control diet
NCT02411838 nacompletednot on this mapstarted 2014, after this paper: background citation

A Pilot Study of Adipokines and Calorie Restriction in Multiple Sclerosis Patients

TypeinterventionalSponsorWashington University School of MedicineRan2014 to 2017Enrolled17ConditionsMultiple SclerosisArmsCalorie restriction
NCT05937802 naunknown statusnot on this mapstarted 2023, after this paper: background citation

Exploratory Trial of Forza™️, a Novel Nutraceutical From Actinidia Deliciosa Plants Bioengineered to Bio-encapsulate the Osmotin Plant Protein as Adjuvant for the Treatment of Progressive Multiple Sclerosis

TypeinterventionalSponsorOspedale Policlinico San MartinoRan2023 to 2025Enrolled50ConditionsProgressive Multiple SclerosisArmsOsmotin
3 · Its place in the literature

Who cites it

120 citing papers in PubMed, 238 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. High Fat Low Carbohydrate Diet Is Linked to CNS Autoimmunity Protection.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  17. Review
  18. Article
  19. Review
  20. Review

60 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Laura PiccioDepartment of Neurology, St. Louis, MO 63110, USA. picciol@neuro.wustl.edu
Jennifer L Stark
Anne H Cross
Washington University in St. Louis · USHope Center for Neurological Disorders · US

Funding

Washington University Nutrition Obesity Research CenterP30DK056341 · NIDDK · WASHINGTON UNIVERSITY · PI Brian N Finck · 1999 to 2026
$30.2M
NIDDK NIH HHS DK56351NIDDK NIH HHS P30 DK056341
6 · The paper itself

Abstract

Calorie restriction (CR) prevents many age-associated diseases and prolongs the lifespan. CR induces multiple metabolic and physiologic modifications, including anti-inflammatory, antioxidant, and neuroprotective effects that may be beneficial in multiple sclerosis (MS). The present studies sought to determine whether CR or increased calorie intake alters the course of experimental autoimmune encephalomyelitis (EAE), the leading animal model for MS. SJL and C57BL/6 mice were subjected to 40% CR beginning at 5 weeks of age. After 5 weeks of CR, EAE was induced by immunizing with proteolipid protein in SJL mice and with myelin oligodendrocyte glycoprotein in C57BL/6 mice. Clinical, histologic, and immunologic features of EAE were compared with mice fed ad libitum and to SJL mice fed a high-fat, high-calorie diet. CR ameliorated clinical EAE in both mouse strains with less severe inflammation, demyelination, and axon injury. No suppression of immune function was observed. A high-calorie diet did not alter the EAE course. CR was associated with increased plasma levels of corticosterone and adiponectin and reduced concentrations of IL-6 and leptin. The CR-induced hormonal, metabolic, and cytokine changes observed in our studies suggest a combined anti-inflammatory and neuroprotective effect. CR with adequate nutrition and careful medical monitoring should be explored as a potential treatment for MS.

Indexed as

Diet, ReducingAnimalsBody CompositionEncephalomyelitis, Autoimmune, ExperimentalFemaleImmunohistochemistryMiceMice, Inbred C57BLMice, Inbred StrainsSecondary Prevention

Identifiers

PMID18678605
PMCPMC2638732
OpenAlexW2168049683

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.